Joshua A. Kazam

Insider Reports History

Entity
Individual
Location
689 5 Th Avenue, 12 Th Floor, New York, NY
Signature
/s/ Allison Frisbee, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Joshua A. Kazam:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Allogene Therapeutics, Inc. Director Stock Option (Right to buy) 191K Jun 5, 2024 Direct
Kronos Bio, Inc. Director Stock Option (Right to Buy) 34K Jun 25, 2024 Direct
TS Innovation Acquisitions Corp. Former Director Class A Common Stock 30K Jun 4, 2021 Direct
TS Innovation Acquisitions Corp. Former Director Class B common stock 0 Jun 4, 2021 Direct

Insider Reports Filed by Joshua A. Kazam

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KRON Kronos Bio, Inc. Jun 25, 2024 1 $0 4 Jun 26, 2024 Director
ALLO Allogene Therapeutics, Inc. Jun 5, 2024 1 $0 4 Jun 7, 2024 Director
KRON Kronos Bio, Inc. Jun 22, 2023 1 $0 4 Jun 26, 2023 Director
ALLO Allogene Therapeutics, Inc. Jun 13, 2023 1 $0 4 Jun 15, 2023 Director
KRON Kronos Bio, Inc. Jun 22, 2022 1 $0 4 Jun 29, 2022 Director
ALLO Allogene Therapeutics, Inc. Jun 15, 2022 1 $0 4 Jun 17, 2022 Director
ALLO Allogene Therapeutics, Inc. Mar 7, 2022 2 $0 4 Mar 9, 2022 Director
ALLO Allogene Therapeutics, Inc. Jan 12, 2022 1 $189K 4 Jan 14, 2022 Director
SCRM Screaming Eagle Acquisition Corp. Jan 5, 2022 0 $0 3 Jan 6, 2022 Director
KRON Kronos Bio, Inc. Jun 22, 2021 1 $0 4 Jun 23, 2021 Director
ALLO Allogene Therapeutics, Inc. Jun 10, 2021 2 $0 4 Jun 11, 2021 Director
LTCH TS Innovation Acquisitions Corp. Jun 4, 2021 2 $0 4 Jun 7, 2021 Former Director
KRON Kronos Bio, Inc. Mar 7, 2021 2 $0 4 Mar 9, 2022 Director